Alexander Fullman

Cooley advised Frame AI, an artificial intelligence-powered platform, on its sale to HubSpot, the leading customer platform for scaling businesses.

Cooley advised Chainbound, a New York-based startup that builds optimized infrastructure and networking tools for blockchains, on its $4.6 million Series Seed financing. Partner Ariel Rom led the Cooley team advising Chainbound.

Cooley advised J2 Ventures, a deep tech venture capital fund focused on new technologies that are critical for both the private sector and the national security interests of the US and its allies, on its $150 million Argonne Fund.

Cooley advised Lexeo Therapeutics, a clinical-stage gene therapy company advancing gene therapy candidates for genetically defined cardiovascular diseases and a genetically defined subgroup of Alzheimer’s disease, on its approximately $100 million initial public offering.

Cooley advised CinCor Pharma, a clinical-stage biopharmaceutical company, on its definitive agreement to be acquired by AstraZeneca. M&A partners Rama Padmanabhan and Rowook Park and corporate partners Div Gupta and Sarah Sellers led the Cooley team.